Search Results
Search for other papers by Jessica L Geiger in
Google Scholar
PubMed
Search for other papers by Simion I Chiosea in
Google Scholar
PubMed
Search for other papers by Sue M Challinor in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Julie E Bauman in
Google Scholar
PubMed
associated with complete obstruction and atelectasis, suspicious for a primary lung neoplasm, as well as bulky right-sided hilar and mediastinal lymphadenopathy ( Fig. 1 A and B). Endobronchial biopsy was consistent with a primary neuroendocrine neoplasm of
Search for other papers by Julien Hadoux in
Google Scholar
PubMed
Search for other papers by Thomas Walter in
Google Scholar
PubMed
Search for other papers by Christina Kanaan in
Google Scholar
PubMed
Search for other papers by Ségolène Hescot in
Google Scholar
PubMed
Search for other papers by Vincent Hautefeuille in
Google Scholar
PubMed
Search for other papers by Marine Perrier in
Google Scholar
PubMed
Laboratoire GReD, Université Clermont Auvergne, Clermont-Ferrand, France
Search for other papers by Igor Tauveron in
Google Scholar
PubMed
Search for other papers by Sandrine Laboureau in
Google Scholar
PubMed
Search for other papers by Christine Do Cao in
Google Scholar
PubMed
Search for other papers by Caroline Petorin in
Google Scholar
PubMed
Search for other papers by Odile Blanchet in
Google Scholar
PubMed
Search for other papers by Matthieu Faron in
Google Scholar
PubMed
Search for other papers by Emmanuelle Leteurtre in
Google Scholar
PubMed
Search for other papers by Marie-Christine Rousselet in
Google Scholar
PubMed
Search for other papers by Juliette Joubert Zakeyh in
Google Scholar
PubMed
Search for other papers by Aude Marchal in
Google Scholar
PubMed
Search for other papers by Denis Chatelain in
Google Scholar
PubMed
Search for other papers by Clément Beaulaton in
Google Scholar
PubMed
Search for other papers by Valérie Hervieu in
Google Scholar
PubMed
Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France
Search for other papers by Michel Ducreux in
Google Scholar
PubMed
Faculté de Médecine, Université Paris Saclay, Le Kremlin-Bicêtre, France
Search for other papers by Jean-Yves Scoazec in
Google Scholar
PubMed
Search for other papers by Eric Baudin in
Google Scholar
PubMed
Search for other papers by the Groupe d’Etude des Tumeurs Endocrines (GTE) in
Google Scholar
PubMed
Search for other papers by the ENDOCAN-RENATEN network in
Google Scholar
PubMed
Patients This was a multicentre retrospective study of seven tertiary centres of the French expert network for the management of neuroendocrine neoplasms ENDOCAN-RENATEN (approved by the French National Cancer Institute, INCa). Patients were diagnosed
Search for other papers by Mojun Zhu in
Google Scholar
PubMed
Search for other papers by Karl R Sorenson in
Google Scholar
PubMed
Search for other papers by Rebecca Liu in
Google Scholar
PubMed
Search for other papers by Bonnie E Gould Rothberg in
Google Scholar
PubMed
Search for other papers by Thorvardur R Halfdanarson in
Google Scholar
PubMed
– 33 . ( https://doi.org/10.1097/MPA.0000000000001454 ) Hua J Shi S Xu J Wei M Zhang Y Liu J Zhang B Yu X 2020 Expression patterns and prognostic value of DNA damage repair proteins in resected pancreatic neuroendocrine neoplasms
Search for other papers by Igryl S Cordero-Hernandez in
Google Scholar
PubMed
Search for other papers by Alicia C Ross in
Google Scholar
PubMed
Search for other papers by Arvind Dasari in
Google Scholar
PubMed
Search for other papers by Daniel M Halperin in
Google Scholar
PubMed
Search for other papers by Beth Chasen in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NEN) are a heterogenous group of malignancies, most commonly arising from gastroenteropancreatic (GEP) sites, with increasing incidence and prevalence worldwide ( Dasari et al. 2017 , Das & Dasari 2021
Search for other papers by Louis de Mestier in
Google Scholar
PubMed
Search for other papers by Angela Lamarca in
Google Scholar
PubMed
Search for other papers by Jorge Hernando in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other papers by Wouter Zandee in
Google Scholar
PubMed
Search for other papers by Teresa Alonso-Gordoa in
Google Scholar
PubMed
Search for other papers by Marine Perrier in
Google Scholar
PubMed
Search for other papers by Annemiek ME Walenkamp in
Google Scholar
PubMed
Search for other papers by Bipasha Chakrabarty in
Google Scholar
PubMed
Search for other papers by Stefania Landolfi in
Google Scholar
PubMed
Search for other papers by Marie-Louise F Van Velthuysen in
Google Scholar
PubMed
Search for other papers by Gursah Kats-Ugurlu in
Google Scholar
PubMed
Search for other papers by Alejandra Caminoa in
Google Scholar
PubMed
Search for other papers by Maxime Ronot in
Google Scholar
PubMed
Search for other papers by Prakash Manoharan in
Google Scholar
PubMed
Search for other papers by Alejandro Garcia-Alvarez in
Google Scholar
PubMed
Search for other papers by Tessa Brabander in
Google Scholar
PubMed
Search for other papers by María Isabel García Gómez-Muriel in
Google Scholar
PubMed
Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed
Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Search for other papers by Jérôme Cros in
Google Scholar
PubMed
Introduction The classification of neuroendocrine neoplasms (NENs) relies on differentiation (well-differentiated neuroendocrine tumors (NETs) or poorly-differentiated neuroendocrine carcinomas (NECs)) and the proliferation index, which is
Search for other papers by Chiara Borga in
Google Scholar
PubMed
Search for other papers by Carlo Alberto Dal Pozzo in
Google Scholar
PubMed
Search for other papers by Elisabetta Trevellin in
Google Scholar
PubMed
Search for other papers by Francesca Bergamo in
Google Scholar
PubMed
Search for other papers by Sabina Murgioni in
Google Scholar
PubMed
Search for other papers by Anna Caterina Milanetto in
Google Scholar
PubMed
Search for other papers by Claudio Pasquali in
Google Scholar
PubMed
Search for other papers by Umberto Cillo in
Google Scholar
PubMed
Search for other papers by Giada Munari in
Google Scholar
PubMed
Search for other papers by Chiara Martini in
Google Scholar
PubMed
Search for other papers by Eugenio De Carlo in
Google Scholar
PubMed
Search for other papers by Vittorina Zagonel in
Google Scholar
PubMed
Search for other papers by Vincenza Guzzardo in
Google Scholar
PubMed
Search for other papers by Gianmaria Pennelli in
Google Scholar
PubMed
Search for other papers by Angelo Paolo Dei Tos in
Google Scholar
PubMed
Search for other papers by Roberto Vettor in
Google Scholar
PubMed
Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
Search for other papers by Matteo Fassan in
Google Scholar
PubMed
Introduction Gastrointestinal neuroendocrine neoplasms (GI-NENs) are a heterogeneous group of malignancies that represent an emerging issue both in research and clinical practice due to their increase in incidence ( Patel & Benipal 2019 ) and
Search for other papers by Andrew McDonald in
Google Scholar
PubMed
Search for other papers by Vaidehi Avadhani in
Google Scholar
PubMed
Search for other papers by Gabriela Oprea-Ilies in
Google Scholar
PubMed
Search for other papers by Katerina Zakka in
Google Scholar
PubMed
Search for other papers by Gregory B Lesinski in
Google Scholar
PubMed
Search for other papers by Olumide B Gbolahan in
Google Scholar
PubMed
Search for other papers by Olatunji Alese in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) of the gastroenteropancreatic (GEP) system are a heterogeneous group of rare malignancies. While the incidence of NENs was relatively low, with 6.98 cases per 100,000 adults in 2012, the incidence
Search for other papers by Matthew H Kulke in
Google Scholar
PubMed
protein that is contained in the neurosecretory vesicles of neuroendocrine tumor cells, and has been identified in the plasma of patients with endocrine neoplasms. Plasma CGA concentrations are a more sensitive marker than urinary 5-HIAA levels in patients
Search for other papers by Martin B Niederle in
Google Scholar
PubMed
Search for other papers by Monika Hackl in
Google Scholar
PubMed
Search for other papers by Klaus Kaserer in
Google Scholar
PubMed
Search for other papers by Bruno Niederle in
Google Scholar
PubMed
Introduction Neuroendocrine tumours (NETs) of the gastrointestinal tract are rare neoplasms and represent a heterogeneous group of tumours with distinct functional and biological behaviour depending on location, tumour size and clinical symptoms
University of Alabama at Birmingham, Department of Surgery, Division of Surgical Oncology, Birmingham, Alabama, USA
Search for other papers by Sarah B Bateni in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Natalie G Coburn in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Search for other papers by Calvin Law in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Simron Singh in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Angela Assal in
Google Scholar
PubMed
Susan Leslie Clinic for Neuroendocrine Tumors, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
Clinical evaluative sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada
Search for other papers by Julie Hallet in
Google Scholar
PubMed
.4160 ) Massironi S Campana D Pusceddu S Albertelli M Faggiano A Panzuto F Smiroldo V Andreasi V Rossi RE Maggio I , 2020 Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: data from a